DBI Peptide - N-terminal region

Aviva Systems Biology

DBI Peptide - N-terminal region

23

Western Blot

Research Use Only

Lyophilized powder

DBI

diazepam binding inhibitor, acyl-CoA binding protein

ACBD1, ACBP, CCK-RP, EP, acyl-CoA-binding protein, GABA receptor modulator, acyl coenzyme A binding protein, acyl-Coenzyme A binding domain containing 1, cholecystokinin-releasing peptide, trypsin-sensitive, diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein), diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A binding protein), diazepam-binding inhibitor, endozepine, epididymis secretory sperm binding protein

This is a synthetic peptide designed for use in combination with anti-DBI Antibody (ARP32803_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

-20°C

41116100

Human